VivoSim Labs Statistics
Total Valuation
VivoSim Labs has a market cap or net worth of $9.46 million. The enterprise value is $1.75 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, after market close.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VivoSim Labs has 2.60 million shares outstanding. The number of shares has increased by 101.37% in one year.
| Current Share Class | 2.60M |
| Shares Outstanding | 2.60M |
| Shares Change (YoY) | +101.37% |
| Shares Change (QoQ) | +53.96% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 5.46% |
| Float | 2.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 48.24 |
| Forward PS | 63.55 |
| PB Ratio | 1.05 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.52, with a Debt / Equity ratio of 0.09.
| Current Ratio | 4.52 |
| Quick Ratio | 4.24 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -867.50 |
Financial Efficiency
Return on equity (ROE) is -24.53% and return on invested capital (ROIC) is -82.93%.
| Return on Equity (ROE) | -24.53% |
| Return on Assets (ROA) | -70.78% |
| Return on Invested Capital (ROIC) | -82.93% |
| Return on Capital Employed (ROCE) | -123.47% |
| Revenue Per Employee | $10,923 |
| Profits Per Employee | -$152,846 |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.67% in the last 52 weeks. The beta is 1.12, so VivoSim Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -41.67% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 62.01 |
| Average Volume (20 Days) | 872,940 |
Short Selling Information
The latest short interest is 37,922, so 1.46% of the outstanding shares have been sold short.
| Short Interest | 37,922 |
| Short Previous Month | 43,477 |
| Short % of Shares Out | 1.46% |
| Short % of Float | 1.47% |
| Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, VivoSim Labs had revenue of $142,000 and -$1.99 million in losses. Loss per share was -$1.11.
| Revenue | 142,000 |
| Gross Profit | -4.87M |
| Operating Income | -12.15M |
| Pretax Income | n/a |
| Net Income | -1.99M |
| EBITDA | -11.89M |
| EBIT | -12.15M |
| Loss Per Share | -$1.11 |
Full Income StatementBalance Sheet
The company has $9.06 million in cash and $822,000 in debt, giving a net cash position of $8.23 million or $3.17 per share.
| Cash & Cash Equivalents | 9.06M |
| Total Debt | 822,000 |
| Net Cash | 8.23M |
| Net Cash Per Share | $3.17 |
| Equity (Book Value) | 9.54M |
| Book Value Per Share | 3.67 |
| Working Capital | 7.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.42 million and capital expenditures -$13,000, giving a free cash flow of -$10.43 million.
| Operating Cash Flow | -10.42M |
| Capital Expenditures | -13,000 |
| Free Cash Flow | -10.43M |
| FCF Per Share | -$4.01 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -8,552.82% |
| Pretax Margin | -1,399.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VivoSim Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -101.37% |
| Shareholder Yield | -101.37% |
| Earnings Yield | -19.90% |
| FCF Yield | -104.49% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 21, 2025. It was a reverse split with a ratio of 1:12.
| Last Split Date | Mar 21, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
VivoSim Labs has an Altman Z-Score of -41.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -41.31 |
| Piotroski F-Score | 3 |
